Detection of anti-HLA-F antibodies in sera from cancer patients

Anticancer Res. 2004 Sep-Oct;24(5C):3387-92.

Abstract

Background: We previously reported that a Q5 gene product (Q5 antigen) on the surface of tumor cells caused humoral immune reaction in syngeneic tumor-bearing mice. Transcripts of the Q5 gene were observed in various tumor cells. The human counterpart of the Q5 gene has not been clarified yet.

Materials and methods: Transcripts of human class Ib genes in various human tumor cell lines were analyzed by the RT-PCR method. Whether anti-HLA-F antibodies were present in sera from cancer patients was investigated through Western blotting with recombinant HLA-F as an antigen.

Results: Transcripts of the HLA-F gene were produced by various tumor cell lines. In addition, anti-HLA-F IgG was present in the sera derived from various types of cancer patients (26 positives / 42 tested), but not in the sera derived from healthy donors (0 / 20).

Conclusion: Anti-HLA-F antibodies should be further investigated as possible diagnostic tumor markers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Antibodies, Neoplasm / blood*
  • Antibodies, Neoplasm / immunology
  • Female
  • Gene Expression / immunology
  • Genes, MHC Class I / genetics
  • HLA Antigens / immunology*
  • HeLa Cells
  • Histocompatibility Antigens Class I / immunology*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Neoplasms / immunology*
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology

Substances

  • Antibodies, Neoplasm
  • HLA Antigens
  • HLA-F antigens
  • Histocompatibility Antigens Class I
  • Immunoglobulin G
  • Recombinant Proteins